Statistics for Tango Therapeutics, (id:6619 TNGX)

Valuation metrics

Market cap

421.08M

Enterprise value

134.27M

Trailing P/E (ttm)

-3.63

Forward P/E

-2.76

PEG ratio

-2.76

Price/Sales (ttm)

9.71

Price/Book (mrq)

1.84

Enterprise Value/Revenue

3.10

Enterprise Value/EBITDA

-0.98

Overview

Shares outstanding

107.42M

Float

60.55M

Shares short

9.08M

% Held by insiders

0.13%

% Held by institutions

1.01%

Average volume (10 days)

3.08M

Average volume (90 days)

Price summary

52-Week low

2.70

52-Week high

13.00

52-Week change

-92.60%

Beta

0.88

50-Day moving average

6.19

200-Day moving average

8.36

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-284.43%

Operating margin

-283.26%

Operational effectiveness

Return on assets

-22.37%

Return on equity

-48.79%

Income statement

Revenue (ttm)

0.40

Revenue per share (ttm)

0.40

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-137,202,000.00

Net income to common (ttm)

-123,395,000.00

Diluted EPS (ttm)

-1.15

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

293.28M

Total cash per share (mrq)

2.73

Total debt (mrq)

37.63M

Total Debt/Equity (mrq)

16.42

Current ratio (mrq)

800.40%

Book value per share (mrq)

2.13

Cash flow

Cash flow statement

-122,321,000.00

Levered free cash flow (LFCF)

-62,539,248.00